Andere Sprachen vTv Therapeutics Inc.

Aktien

A3EWXG

US9183852048

VTVT

Verzögert Nasdaq Andere Börsenplätze 22:30:00 25.04.2024			% 5 Tage	% 1. Jan.
25,77 ^USD	+1,06 %		+4,16 %	+124,09 %

14.03.	VTv Therapeutics Inc. kündigt Änderungen im Vorstand an	CI
13.03.	VTv Therapeutics Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT	19.03.
VTv Therapeutics Inc. Announces Board Changes	14.03.
VTv Therapeutics: Q4 Earnings Snapshot	13.03.
VTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update	13.03.
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13.03.
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	04.03.
VTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	04.03.
VTv Therapeutics Inc. Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	04.03.
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	01.03.
Top Midday Gainers	28.02.
VTv Therapeutics Inc. Announces Board Changes	28.02.
VTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund	28.02.
VTv Therapeutics Inc. announced that it has received $50.961457 million in funding from JDRF T1D Fund, Samsara BioCapital LLC and another investors	27.02.
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE	22.02.
Vtv Therapeutics Inc. Announces Resignation of Chandresh Harjivan as Member of the Board of Directors	22.12.
VTv Therapeutics: Q3 Earnings Snapshot	09.11.
VTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update	09.11.
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
VTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference	08.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen vTv Therapeutics Inc.

Aktien

A3EWXG

US9183852048

VTVT

Andere Sprachen

Filter